Skip to main content


5 result(s) for 'author#Marcin Krzystanek' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. Stage I lung adenocarcinoma is usually not treated with adjuvant chemotherapy; however, around half of these patients do not survive 5 years. Therefore, a reliable prognostic biomarker for early stage patients...

    Authors: Marcin Krzystanek, Judit Moldvay, David Szüts, Zoltan Szallasi and Aron Charles Eklund
    Citation: Biomarker Research 2016 4:4
  2. A substantial proportion of cancer cases present with a metastatic tumor and require further testing to determine the primary site; many of these are never fully diagnosed and remain cancer of unknown primary ...

    Authors: Andrea Marion Marquard, Nicolai Juul Birkbak, Cecilia Engel Thomas, Francesco Favero, Marcin Krzystanek, Celine Lefebvre, Charles Ferté, Mariam Jamal-Hanjani, Gareth A. Wilson, Seema Shafi, Charles Swanton, Fabrice André, Zoltan Szallasi and Aron Charles Eklund
    Citation: BMC Medical Genomics 2015 8:58
  3. Ovarian and triple-negative breast cancers with BRCA1 or BRCA2 loss are highly sensitive to treatment with PARP inhibitors and platinum-based cytotoxic agents and show an accumulation of genomic scars in the f...

    Authors: Andrea M Marquard, Aron C Eklund, Tejal Joshi, Marcin Krzystanek, Francesco Favero, Zhigang C Wang, Andrea L Richardson, Daniel P Silver, Zoltan Szallasi and Nicolai J Birkbak
    Citation: Biomarker Research 2015 3:9
  4. Genomic mutations caused by cytotoxic agents used in cancer chemotherapy may cause secondary malignancies as well as contribute to the evolution of treatment-resistant tumour cells. The stable diploid genome o...

    Authors: Bernadett Szikriszt, Ádám Póti, Orsolya Pipek, Marcin Krzystanek, Nnennaya Kanu, János Molnár, Dezső Ribli, Zoltán Szeltner, Gábor E. Tusnády, István Csabai, Zoltan Szallasi, Charles Swanton and Dávid Szüts
    Citation: Genome Biology 2016 17:99
  5. Detection of somatic mutations is one of the main goals of next generation DNA sequencing. A wide range of experimental systems are available for the study of spontaneous or environmentally induced mutagenic p...

    Authors: O. Pipek, D. Ribli, J. Molnár, Á. Póti, M. Krzystanek, A. Bodor, G. E. Tusnády, Z. Szallasi, I. Csabai and D. Szüts
    Citation: BMC Bioinformatics 2017 18:73